The Role of chemokine receptor CXCR4 in the biologic behavior of human soft tissue sarcoma

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Kim, Roger H ^a   Li, Benjamin D L ^a   Chu, Quyen D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMD 31000; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CTCE 9908; INTERSTITIAL COLLAGENASE; PLERIXAFOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOSARCOMA; BONE METASTASIS; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CHONDROSARCOMA; CLEAR CELL SARCOMA; DIGESTIVE SYSTEM CANCER; EPITHELIOID SARCOMA; FIBROSARCOMA; GLIOBLASTOMA; HUMAN; LEIOMYOSARCOMA; LIPOSARCOMA; LUNG CANCER; LUNG METASTASIS; LUNG SARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MELANOMA; METASTASIS; NERVE SHEATH TUMOR; NONHODGKIN LYMPHOMA; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA;

EID: 79952219911     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/593708     Document Type: Review

References (34)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., Thun M. J., Cancer statistics, 2006 Ca: A Cancer Journal for Clinicians 2006 56 2 106 130
2. Lahat G., Lazar A., Lev D., Sarcoma epidemiology and etiology: potential environmental and genetic factors Sur (Pubitemid 351734513)
3. Fletcher C. D. M., Recommendations for the reporting of soft tissue sarcomas: Association of Directors of Anatomic and Surgical Pathology Modern Pathology 1998 11 12 1257 1261 (Pubitemid 29009338)
4. Ordez J. L., Osuna D., Garca-Domnguez D. J., Amaral A. T., Otero-Motta A. P., MacKintosh C., Sevillano M. V., Barbado M. V., Hernndez T., De Alava E., The clinical relevance of molecular genetics in soft tissue sarcomas Advances in Anatomic Pathology 2010 17 3 162 181
5. Teicher B. A., Fricker S. P., CXCL12 (SDF-1)/CXCR4 pathway in cancer Clinical Cancer Research 2010 16 11 2927 2931
6. Balkwill F., Cancer and the chemokine network Nature Reviews Cancer 2004 4 7 540 550 (Pubitemid 38868623)
7. Murakami T., Maki W., Cardones A. R., Fang H., Tun Kyi A., Nestle F. O., Hwang S. T., Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells Cancer Research 2002 62 24 7328 7334 (Pubitemid 36025256)
8. Smith M. C. P., Luker K. E., Garbow J. R., Prior J. L., Jackson E., Piwnica-Worms D., Luker G. D., CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Research 2004 64 23 8604 8612 (Pubitemid 39552073)
9. Taichman R. S., Cooper C., Keller E. T., Pienta K. J., Taichman N. S., McCauley L. K., Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone Cancer Research 2002 62 6 1832 1837 (Pubitemid 34408510)
10. Mller A., Homey B., Soto H., Ge N., Catron D., Buchanan M. E., McClanahan T., Murphy E., Yuan W., Wagner S. N., Barrera J. L., Mohar A., Verstegui E., Zlotnik A., Involvement of chemokine receptors in breast cancer metastasis Nature 2001 410 6824 50 56 (Pubitemid 32225831)
11. Murakami T., Cardones A. R., Hwang S. T., Chemokine receptors and melanoma metastasis Journal of Dermatological Science 2004 36 2 71 78 (Pubitemid 39424129)
12. Chu Q. D., Panu L., Holm N. T., Li B. D. L., Johnson L. W., Zhang S., High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome Journal of Surgical Research 2010 159 2 689 695
13. Darash-Yahana M., Pikarsky E., Abramovitch R., Zeira E., Pal B., Karplus R., Belder K., Avniel S., Kasem S., Galun E., Peled A., Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis The FASEB Journal 2004 18 11 1240 1242 (Pubitemid 39561563)
14. Burger J. A., Stewart D. J., CXCR4 chemokine receptor antagonists: perspectives in SCLC Expert Opinion on Investigational Drugs 2009 18 4 481 490
15. Schimanski C. C., Schwald S., Simiantonaki N., Jayasinghe C., Gnner U., Wilsberg V., Junginger T., Berger M. R., Galle P. R., Moehler M., Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer Clinical Cancer Research 2005 11 5 1743 1750 (Pubitemid 40471835)
16. Meier R., Mhlethaler-Mottet A., Flahaut M., Coulon A., Fusco C., Louache F., Auderset K., Bourloud K. B., Daudigeos E., Ruegg C., Vassal G., Gross N., Joseph J. M., The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion PLoS One 2007 2 10
17. Laverdiere C., Hoang B. H., Yang R., Sowers R., Qin J., Meyers P. A., Huvos A. G., Healey J. H., Gorlick R., Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma Clinical Cancer Research 2005 11 7 2561 2567 (Pubitemid 40569454)
18. Perissinotto E., Cavalloni G., Leone F., Fonsato V., Mitola S., Grignani G., Surrenti N., Sangiolo D., Bussolino F., Piacibello W., Aglietta M., Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression Clinical Cancer Research 2005 11 2 490 497 (Pubitemid 40116871)
19. Oda Y., Yamamoto H., Tamiya S., Matsuda S., Tanaka K., Yokoyama R., Iwamoto Y., Tsuneyoshi M., CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: Analysis within a group of patients, all of whom developed lung metastasis Modern Pathology 2006 19 5 738 745
20. Kim S. Y., Lee C. H., Midura B. V., Yeung C., Mendoza A., Hong S. H., Ren L., Wong D., Korz W., Merzouk A., Salari H., Zhang H., Hwang S. T., Khanna C., Helman L. J., Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases Clinical and Experimental Metastasis 2008 25 3 201 211
21. Strahm B., Durbin A. D., Sexsmith E., Malkin D., The CXCR4-SDF1 axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma Clinical and Experimental Metastasis 2008 25 1 1 10 (Pubitemid 351191222)
22. Libura J., Drukala J., Majka M., Tomescu O., Navenot J. M., Kucia M., Marquez L., Peiper S. C., Barr F. G., Janowska-Wieczorek A., Ratajczak M. Z., CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion Blood 2002 100 7 2597 2606
23. Diomedi-Camassei F., McDowell H. P., De loris M. A., Uccini S., Altavista P., Raschell G., Vitali R., Mannarino O., De Sio L., Cozzi D. A., Donfrancesco A., Inserra A., Callea F., Dominici C., Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma Clinical Cancer Research 2008 14 13 4119 4127
24. Jankowski K., Kucia M., Wysoczynski M., Reca R., Zhao D., Trzyna E., Trent J., Peiper S., Zembala M., Ratajczak J., Houghton P., Janowska-Wieczorek A., Ratajczak M. Z., Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy Cancer Research 2003 63 22 7926 7935 (Pubitemid 37466729)
25. Sun X., Wei L., Chen Q., Terek R. M., CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression Molecular Cancer 2010 9, article 17
26. Lai T. H., Fong YI. C., Fu W. M., Yang R. S., Tang C. H., Stromal cell-derived factor-1 increase v 3 integrin expression and invasion in human chondrosarcoma cells Journal of Cellular Physiology 2009 218 2 334 342
27. Bennani-Baiti I. M., Cooper A., Lawlor E. R., Kauer M., Ban J., Aryee D. N.T., Kovar H., Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma Clinical Cancer Research 2010 16 14 3769 3778
28. Chansky H. A., Barahmand-pour F., Mei Q., Kahn-Farooqi W., Zielinska-Kwiatkowska A., Blackburn M., Chansky K., Conrad E. U., Bruckner J. D., Greenlee T. K., Yang L., Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro Journal of Orthopaedic Research 2004 22 4 910 917 (Pubitemid 38756277)
29. Maeda T., Hashitani S., Zushi Y., Segawa E., Tanaka N., Sakurai K., Urade M., Establishment of a nude mouse transplantable model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung Journal of Cancer Research and Clinical Oncology 2008 134 9 1005 1011
30. Oda Y., Tateishi N., Matono H., Matsuura S., Yamamaoto H., Tamiya S., Yokoyama R., Matsuda S., Iwamoto Y., Tsuneyoshi M., Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma International Journal of Cancer 2009 124 8 1852 1859
31. De Clercq E., Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil ) and potential of other CXCR4 antagonists as stem cell mobilizers Pharmacology and Therapeutics 2010 128 3 509 518
32. Pusic I., Dipersio J. F., Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells Current Opinion in Hematology 2010 17 4 319 326
33. Kast R. E., Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct Turkish Neurosurgery 2010 20 4 425 429
34. Schimanski C. C., Galle P. R., Moehler M., Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors World Journal of Gastroenterology 2008 14 30 4721 472